Genesis Drug Discovery & Development (GD³) is a member of Genesis Global Group, established in 2017. The company specializes in contract research services catering to preclinical drug development programs from discovery to candidate selection. Their diverse portfolio includes services in Discovery Biology, Chemistry, DMPK/in-vivo pharmacology, and Toxicology, covering therapeutic areas such as oncology, ocular, inflammation, metabolic diseases, and microbiome. With its slogan "Our Science for Your Science," GD³ is dedicated to supporting the pharmaceutical industry's preclinical research needs. Although the specific headquarter location and the recent investment details are undisclosed, it operates within the Manufacturing and Pharmaceutical industries.
There is no investment information
No recent news or press coverage available for Genesis Drug Discovery & Development (GD³).